Buy One Get One free -Llimited Time Offer X
Turbovas F is a prescription drug, available for use as Tablet. The alternative uses of Turbovas F have also been explained below.
The optimal dosage of Turbovas F is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Turbovas F are Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Turbovas F as well, which are listed below. Usually, these side effects of Turbovas F go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Turbovas F has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Turbovas F has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Turbovas F related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Turbovas F since this can cause severe adverse effects.
Additionally, Turbovas F may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Turbovas F is not safe while driving, and is is not addictive in nature.
Turbovas F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Turbovas F safe for pregnant women?
Turbovas F can have harmful effects in pregnant women. If you experience any discomfort after using Turbovas F, then discontinue the use and take your doctor's advice.
Is the use of Turbovas F safe during breastfeeding?
Turbovas F can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Turbovas F on the Kidneys?
Turbovas F rarely affects the kidneys.
What is the effect of Turbovas F on the Liver?
Very few cases of side effects of Turbovas F on the liver have been reported.
What is the effect of Turbovas F on the Heart?
There may be an adverse effect on the heart after taking Turbovas F. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Turbovas F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Turbovas F unless your doctor advises you to do so -
Is this Turbovas F habit forming or addictive?
No, there is no any evidence that Turbovas F is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Turbovas F can make you feel drowsy.
Is it safe?
Turbovas F should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Turbovas F in mental disorders is not effective.
Interaction between Food and Turbovas F
There is no information on the effects of taking Turbovas F with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Turbovas F
It is difficult to say anything about the effect of Turbovas F and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650